Amy B. Kolbe

Amy B. Kolbe

Auto-generated profile, based on publicly available information

Amy B. Kolbe

Division of Pediatric Radiology, Mayo Clinic, Rochester, Minnesota

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Radiology
Verified
Journal Article
Closed access
JMJennifer S. McDonald
Jennifer S. McDonald
Nicholas B LarsonNicholas B Larson
Nicholas B Larson
AKAmy B. Kolbe
Amy B. Kolbe
CHChristopher Harker Hunt
Christopher Harker Hunt
JSJohn Joseph Schmitz
John Joseph Schmitz
RMRobert J. McDonald
Robert J. McDonald
The study findings do not support the efficacy of steroid premedication (oral methylprednisolone at 12 and 2 hours) for preventing repeat allergic-like reactions in high-risk patients. Background It is unclear whether steroid premedication is an effective means of preventing repeat allergic-like reactions in high-risk patients with a previous allergic-like reaction to iodinated c...

1 January 2023 in RadioGraphics
Verified
Journal Article
Closed access
GCGovind B. Chavhan
Govind B. Chavhan
GSGary R. Schooler
Gary R. Schooler
ETElizabeth R. Tang
Elizabeth R. Tang
JSJudy H. Squires
Judy H. Squires
MRMitchell A. Rees
Mitchell A. Rees
ATAlexander J. Towbin
Alexander J. Towbin
Imaging plays an important role in the diagnosis and management of focal liver lesions, and patient-related factors such as age, size, cardiac function, and ability to cooperate for imaging examina... A differential diagnosis based on a patient’s age, clinical presentation, and serum α-fetoprotein level will help guide the initial imaging workup in children with a liver lesion. Children vary sig...

5 January 2014 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
AKAmy B. Kolbe
Amy B. Kolbe
RHRobert P. Hartman
Robert P. Hartman
THTanya L. Hoskin
Tanya L. Hoskin
RCRickey E. Carter
Rickey E. Carter
DMDaniel E. Maddox
Daniel E. Maddox
GHGina K. Hesley
Gina K. Hesley

1 September 2023 in RadioGraphics
Verified
Journal Article
Closed access
CMCara Morin
Cara Morin
AKAmy B. Kolbe
Amy B. Kolbe
AAAdina Alazrkai
Adina Alazrkai
GCGovind B. Chavhan
Govind B. Chavhan
AGAnnie Gill
Annie Gill
GSGary R. Schooler
Gary R. Schooler
The liver is the primary organ for the metabolism of many chemotherapeutic agents. Treatment-induced liver injury is common in children undergoing cancer therapy. Hepatic injury occurs due to various mechanisms, including biochemical cytotoxicity, hepatic vascular injury, radiation-induced cytotoxicity, and direct hepatic injury through minimally invasive and invasive surgical treatments. Treatment-induced liver injury can be seen contemporaneous with therapy and months to years after therapy is complete. Patients can develop a combination of hepatic injuries manifesting during and after treatment. Acute toxic effects of cancer therapy in children include hepatitis, steatosis, steatohepatitis, cholestasis, hemosiderosis, and vascular injury. Longer-term effects of cancer therapy include hepatic fibrosis, chronic liver failure, and development of focal liver lesions. Quantitative imaging techniques can provide useful metrics for disease diagnosis and monitoring, especially in treatment-related diffuse liver injury such as hepatic steatosis and steatohepatitis, hepatic iron deposition, and hepatic fibrosis. Focal liver lesions, including those developing as a result of treatment-related vascular injury such as focal nodular hyperplasia-like lesions and hepatic perfusion anomalies, as well as hepatic infections occurring as a consequence of immune suppression, can be anxiety provoking and confused with recurrent malignancy or hepatic metastases, although there often are imaging features that help elucidate the correct diagnosis. Radiologic evaluation, in conjunction with clinical and biochemical screening, is integral to diagnosing and monitoring hepatic complications of cancer therapy in pediatric patients during therapy and after therapy completion for long-term surveillance. ©RSNA, 2023 Quiz questions for this article are available in the supplemental material See the invited commentary by Ferraciolli and Gee in this issue.

1 November 2019 in Radiology Case Reports
Verified
Journal Article
Open access
AKAmy B. Kolbe
Amy B. Kolbe
AMArnold C. Merrow
Arnold C. Merrow
LELaurence J. Eckel
Laurence J. Eckel
PKPeter Kalina
Peter Kalina
RRRodrigo Ruano
Rodrigo Ruano
We report the presentation, workup, and pre/perinatal management of a fetus with a large congenital hemangioma of the face. Hemangiomas are benign vascular neoplasms frequently encountered in neonates and infants. The less common congenital variant develops in utero and can present on prenatal ultrasound with diagnostic uncertainty as well as clinical implications for delivery. The differential diagnosis for these solid vascular masses when located in the head and neck includes myofibroma, kaposiform hemangioendothelioma, teratoma, and encephalocele. Potential clinical issues relate to size and location of the mass and include airway obstruction, disruption in development or compression of the globe, invasion into the cranial vault, bleeding and ulceration, and high output heart failure. Prenatal ultrasound and MRI play an important role in the diagnosis of congenital hemangiomas and planning for delivery and immediate postnatal cares.

28 July 2022 in Clinical Imaging
Verified
Journal Article
Closed access
PDF file
JMJennifer S. McDonald
Jennifer S. McDonald
KHKelly K. Horst
Kelly K. Horst
PTPaul G. Thacker
Paul G. Thacker
KTKristen B. Thomas
Kristen B. Thomas
DKDenise B. Klinkner
Denise B. Klinkner
AKAmy B. Kolbe
Amy B. Kolbe